vascuCAP® Clinical Edition

First-ever FDA and CE cleared non-invasive tool to objectively measure all key characteristics of high-risk plaque, validated against histopathology

Left Carotid

Use Cases

Determine Optimal Medical Therapy

Stratify Risk of Event

Track Response to Therapeutic

Plan Procedures

Arteries

Aorta

Carotid

Coronary

Femoral

Intracranial

Only non-invasive test that allows analysis of all key biomarkers, leading to unprecedented specificity:​​

  • Stenosis, remodeling, and ulceration

​​

  • Atherosclerotic plaque burden and structural measures of magnitude and stage

​​

  • Tissue characterization in vessel wall

Patented Computer-Aided Phenotyping® allows users to identify imaging biomarkers of plaque stability

Histology-validated Plaque Morphology Viewer and Risk Ratio

Tissue Types:​ Lipid Rich Necrotic Core, Calcification, & Matrix

Purchase Models

Software License

  • Software is purchased and installed locally at customer site

​​

  • Report is easily accessible to physicians and care team

​​

  • Elucid provides training and remote customer support

Elucid Analysis

  • Elucid receives secure transfer of image and performs analysis

​​

  • Report is easily accessible to physicians and care team

Aorta

First FDA-cleared use of advanced knowledge representation, and roadmap of progressive and robust machine intelligence

Reporting for the referring physician:

  • Interactive report displaying discrete measurements of key properties along the vessel

​​

  • Longitudinal progression/regression plots

​​

  • Easy toggle to narrative version of report to provide easily-digestible key takeaways for provider note

Â